LT2643342T - Naujieji 2 tipo angiotenzino (at2) receptoriaus agonistai ir jų panaudojimas - Google Patents

Naujieji 2 tipo angiotenzino (at2) receptoriaus agonistai ir jų panaudojimas

Info

Publication number
LT2643342T
LT2643342T LTEP11791636.1T LT11791636T LT2643342T LT 2643342 T LT2643342 T LT 2643342T LT 11791636 T LT11791636 T LT 11791636T LT 2643342 T LT2643342 T LT 2643342T
Authority
LT
Lithuania
Prior art keywords
receptor agonists
angiotensin type
novel angiotensin
novel
type
Prior art date
Application number
LTEP11791636.1T
Other languages
English (en)
Inventor
Louwe De Vries
Sieger Adriaan Nelemans
Rick Rink
Antonius Jacobus Marinus Roks
Gert Nikolaas Moll
Original Assignee
Lanthiopep B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lanthiopep B.V. filed Critical Lanthiopep B.V.
Publication of LT2643342T publication Critical patent/LT2643342T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
LTEP11791636.1T 2010-11-23 2011-11-22 Naujieji 2 tipo angiotenzino (at2) receptoriaus agonistai ir jų panaudojimas LT2643342T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10192208A EP2455388A1 (en) 2010-11-23 2010-11-23 Novel angiotensin type 2 (AT2) receptor agonists and uses thereof.
PCT/NL2011/050793 WO2012070936A1 (en) 2010-11-23 2011-11-22 Novel angiotensin type 2 (at2) receptor agonists and uses thereof

Publications (1)

Publication Number Publication Date
LT2643342T true LT2643342T (lt) 2017-09-11

Family

ID=44072497

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP11791636.1T LT2643342T (lt) 2010-11-23 2011-11-22 Naujieji 2 tipo angiotenzino (at2) receptoriaus agonistai ir jų panaudojimas

Country Status (19)

Country Link
US (4) US9290540B2 (lt)
EP (2) EP2455388A1 (lt)
JP (2) JP5837087B2 (lt)
KR (1) KR101512916B1 (lt)
CN (1) CN103314006B (lt)
AU (1) AU2011332397B2 (lt)
CA (1) CA2818299C (lt)
CY (1) CY1119036T1 (lt)
DK (1) DK2643342T3 (lt)
ES (1) ES2632553T3 (lt)
HR (1) HRP20171048T1 (lt)
HU (1) HUE035167T2 (lt)
LT (1) LT2643342T (lt)
NZ (1) NZ610732A (lt)
PL (1) PL2643342T3 (lt)
PT (1) PT2643342T (lt)
RS (1) RS56130B1 (lt)
SI (1) SI2643342T1 (lt)
WO (1) WO2012070936A1 (lt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102013023224B1 (pt) * 2012-09-14 2023-02-07 Universidade Federal De Minas Gerais PEPTÍDEO (ARGº)N-ANGIOTENSINA-(1-7) E COMPOSIÇÕES FARMACÊUTICAS PARA TRATAMENTO DE DOENÇAS
US8633158B1 (en) * 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
WO2015002903A1 (en) * 2013-07-03 2015-01-08 Arizona Board Of Regents For The University Of Arizona Method for treating cognitive dysfunction
AU2015294371B2 (en) 2014-07-21 2018-02-01 The Arizona Board Of Regents On Behalf Of The University Of Arizona Ang-(1-7) derivative oligopeptides and methods for using and producing the same
US10183055B2 (en) 2014-07-21 2019-01-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
ES2892957T3 (es) 2014-11-19 2022-02-07 Novopyxis Inc Composiciones y métodos de modulación de la actividad de AT2R
WO2016107879A2 (en) * 2014-12-30 2016-07-07 Vicore Pharma Ab New use of angiotensin ii receptor agonists
EP3820498A1 (en) * 2018-06-14 2021-05-19 University College Cork-National University of Ireland Cork Peptide for disease treatment
CN110333302A (zh) * 2019-06-25 2019-10-15 武汉兴华智慧医药科技有限公司 乙酰半胱氨酸溶液中n，n-二乙酰基羊毛硫氨酸的检测方法
JP2022542437A (ja) 2019-08-02 2022-10-03 ランティオペプ ベスローテン ヴェンノーツハップ 癌の処置に用いるアンジオテンシン２型（ａｔ２）受容体アゴニスト
KR102488519B1 (ko) * 2020-07-22 2023-01-13 순천대학교 산학협력단 신규 고리형 펜타뎁시펩타이드 화합물 및 이를 유효성분으로 함유하는 상처 치유 또는 재생용 조성물

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6443695A (en) 1987-08-07 1989-02-15 Sun Tech Inc Casing expansion joint device in excavator
US5240928A (en) 1989-07-03 1993-08-31 Merck & Co., Inc. Substituted quinazolinones as angiotensin II antagonists
EP0409332A3 (en) 1989-07-19 1991-08-07 Merck & Co. Inc. Substituted triazoles as angiotensin ii antagonists
US5166206A (en) 1990-03-30 1992-11-24 Merck & Co., Inc. Substituted pyrimidines, pyrimidinones and pyridopyrimidines
US5091390A (en) 1990-09-20 1992-02-25 E. I. Du Pont De Nemours And Company Treatment of CNS disorders with 4,5,6,7-tetrahydro-1H-imidazo (4,5-)-pyridines and analogs
EP0481614A1 (en) 1990-10-01 1992-04-22 Merck & Co. Inc. Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists
US5260285A (en) 1990-12-07 1993-11-09 Merck & Co., Inc. Substituted imidazopyridazines as angiotensin II antagonists
US5250521A (en) 1990-12-07 1993-10-05 Merck & Co., Inc. Substituted pyrazolopyrimidines as angiotensin II antagonists
CA2062558A1 (en) 1991-03-08 1992-09-09 Prasun K. Chakravarty Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists
US5177074A (en) 1991-03-26 1993-01-05 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted thiophene or furan
US5252574A (en) 1991-04-26 1993-10-12 Merck & Co., Inc. Angiotensin II antagonists incorporating a substituted thiophene or furan
US5198438A (en) 1991-05-07 1993-03-30 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted thiophene or furan
US5312820A (en) 1992-07-17 1994-05-17 Merck & Co., Inc. Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
US5554625A (en) 1992-07-17 1996-09-10 Merck & Co., Inc. Substituted biphenylmethylimidazopyridines
US5310929A (en) 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
US5376666A (en) 1992-11-30 1994-12-27 The Du Pont Merck Pharmaceutical Company Angiotension-II receptor blocking, azacycloalkyl or azacycloalkenyl
WO1994027597A1 (en) 1993-05-21 1994-12-08 Smithkline Beecham Corporation Imidazolyl-alkenoic acid angiotensin ii receptor antagonists
FR2716882B1 (fr) 1994-03-04 1996-04-05 Roussel Uclaf Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques.
US5834432A (en) 1995-06-06 1998-11-10 The University Of Southern California Use of angiotensin II Type 2 receptor agonists in tissue repair
JPH10203981A (ja) 1997-01-21 1998-08-04 Kureha Chem Ind Co Ltd 心疾患改善剤
AU6650098A (en) 1997-02-04 1998-08-25 University Of Southern California Method for accelerating healing of thermal injuries
AU748903B2 (en) * 1997-06-24 2002-06-13 Proteus Molecular Design Limited Angiotensin derivatives
CA2310852A1 (en) 1997-11-26 1999-06-03 University Of Southern California Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
CA2321168A1 (en) 1998-02-09 1999-08-12 University Of Southern California Method of promoting keratinocyte proliferation
WO1999039743A2 (en) 1998-02-09 1999-08-12 University Of Southern California Method of promoting hepatic cell proliferation
CA2319701C (en) 1998-02-09 2009-09-29 University Of Southern California Method of promoting erythropoiesis
AU2680999A (en) 1998-02-19 1999-09-06 University Of Southern California Method of promoting embryonic stem cell proliferation
SE9800550D0 (sv) 1998-02-24 1998-02-24 A & Science Invest Ab A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
JP3728400B2 (ja) 1998-03-10 2005-12-21 ユニヴァースティ オブ サザーン カリフォルニア 改良型放射線治療の諸方法
US6498138B1 (en) 1998-03-11 2002-12-24 University Of Southern California Method of promoting production of living tissue equivalents
WO1999052540A1 (en) 1998-04-09 1999-10-21 University Of Southern California Methods for treatment and prevention of infections
EP1073453B1 (en) 1998-05-11 2005-04-13 University Of Southern California Use of angiotensin analogs for the manufacture of a medicament for increasing white blood cell survival and mobilizing haematopoietic progenitor cells following chemotherapy
AU756785B2 (en) 1998-07-13 2003-01-23 University Of Southern California Methods for accelerating bone and cartilage growth and repair
CA2339330A1 (en) 1998-08-13 2000-02-24 University Of Southern California Methods to increase blood flow to ischemic tissue
CZ297795B6 (cs) 1998-12-23 2007-03-28 Novartis Ag Tablety obsahující valsartan
WO2000056345A2 (en) 1999-03-23 2000-09-28 University Of Southern California Methods for limiting scar and adhesion formation
DE60222409T2 (de) 2001-05-31 2008-09-25 Vicore Pharma Ab Trizyklische verbindungen, nützlich als angiotensin ii agonisten
AU2003286251A1 (en) 2002-11-21 2004-06-15 Vicore Pharma Ab New bicyclic angiotensin ii agonists
WO2008130217A1 (en) * 2006-08-08 2008-10-30 Applied Nanosystems B.V. Cyclic angiotensin analogs
BRPI0800585B8 (pt) * 2008-02-13 2021-05-25 Univ Minas Gerais composições farmacêuticas do peptídeo des-[asp1]-[ala1]-angiotensina-(1-7) e uso do peptídeo des-[asp1]-[ala1]-angiotensina-(1-7)

Also Published As

Publication number Publication date
NZ610732A (en) 2014-05-30
DK2643342T3 (en) 2017-07-24
KR101512916B1 (ko) 2015-04-16
ES2632553T3 (es) 2017-09-14
AU2011332397A1 (en) 2013-05-02
CN103314006B (zh) 2016-04-13
WO2012070936A1 (en) 2012-05-31
KR20130099178A (ko) 2013-09-05
RS56130B1 (sr) 2017-10-31
US20140094400A1 (en) 2014-04-03
JP2016074675A (ja) 2016-05-12
US9707268B2 (en) 2017-07-18
EP2643342B1 (en) 2017-04-12
PL2643342T3 (pl) 2017-09-29
HUE035167T2 (en) 2018-05-02
EP2455388A1 (en) 2012-05-23
PT2643342T (pt) 2017-07-12
AU2011332397B2 (en) 2015-11-05
SI2643342T1 (sl) 2017-08-31
US9290540B2 (en) 2016-03-22
US20190135867A1 (en) 2019-05-09
CY1119036T1 (el) 2018-01-10
US20160220632A1 (en) 2016-08-04
HRP20171048T1 (hr) 2017-10-06
EP2643342A1 (en) 2013-10-02
JP2014503506A (ja) 2014-02-13
CN103314006A (zh) 2013-09-18
CA2818299A1 (en) 2012-05-31
JP5837087B2 (ja) 2015-12-24
CA2818299C (en) 2018-12-04
US20170283465A1 (en) 2017-10-05
US10214563B2 (en) 2019-02-26

Similar Documents

Publication Publication Date Title
HUS2100032I1 (hu) Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk
RS56130B1 (sr) Novi agonisti angiotenzinskog receptora tipa 2 (at2) i njihove upotrebe
IL222961A0 (en) Novel dna-dinding proteins and uses thereof
HK1185368A1 (en) Heat-curable polyorganosiloxane composition and use thereof
EP2552953A4 (en) FRIZZLED-BINDING SUBSTANCES AND ITS USES
PT2946791T (pt) Anticorpos anti-cd277 e suas utilizações
EP2638065A4 (en) ACTRIIA BINDING AGENTS AND USES THEREOF
HK1179981A1 (zh) 的抗體及其用途
HRP20160922T1 (hr) Oligopeptidni spojevi i njihove uporabe
PL2588491T3 (pl) Nowy peptyd i jego zastosowanie
IL210773A0 (en) Neuropeptide-2 receptor (y-2r) agonists and uses thereof
HK1180720A1 (en) Stabilized alpha galactosidase and uses thereof
EP2632952A4 (en) ANTI-SOD1 ANTIBODIES AND USES THEREOF
IL212364A0 (en) Neuropeptide-2-receptor (y-2r) agonists and uses thereof
EP2608785A4 (en) LIPOMA CYCLES AND ITS USES
IL219987A0 (en) Dp2 antagonist and uses thereof
EP2610619A4 (en) HEMOCININE-1 RECEPTOR AND HEMOCININE-1-PEPTIDE
EP2529013A4 (en) NOVEL BETA GLUCOSIDASE AND USES THEREOF
HK1166493A1 (zh) 維生素 受體激動劑及其用途
EP2545378A4 (en) ANTI-LG3 ANTIBODIES AND USES THEREOF
EP2619580A4 (en) SOLUTION MICROARRAYS AND USES THEREOF
EP2544677A4 (en) BETA-ADRENERGIC RECEPTOR AGONISTS AND USES THEREOF
GB201011848D0 (en) Bale handler "portabale"
GB201002934D0 (en) You're secure
GB201014319D0 (en) Compounds and uses thereof